Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

23andMe files for bankruptcy, CEO resigns

The news: Embattled direct-to-consumer genetic testing company 23andMe filed for federal bankruptcy protection and announced the resignation of CEO Anne Wojcicki. 23andMe’s stock plummeted nearly 60% on Monday following its Sunday night filing.

How we got here: 23andMe was a market trailblazer in the DNA testing segment, becoming the first company to sell FDA-approved genetic tests to consumers. People grew fascinated with the idea of taking a test to uncover insights about their ancestry, helping 23andMe reach a $6 billion peak valuation after going public in 2021.

However, a series of operational difficulties and company missteps followed:

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account